Klos, Kristine S.

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients

Nagata, Y., Lan, K.-H., Zhou, X., Tan, M., Esteva, F. J., Sahin, A. A., Klos, K. S., Li, P., Monia, B. P., Nguyen, N. T., et al. (2004) · Cancer Cell

HER2/EGFR in Cancer ResearchPI3K/AKT/mTOR signaling in cancer

Cited by 1,858

Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development

McDermott, S. P., Ranheim, E. A., Leatherberry, V. S., Khwaja, S. S., Klos, K. S., & Alexander, C. M. (2007) · Oncogene

Proteoglycans and glycosaminoglycans researchCancer Cells and Metastasis

Cited by 61